$4.87 1.4%
EVO Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.


Evotec
Price $4.87
Target Price Sign up
Volume 35,580
Market Cap $1.75B
Year Range $4.07 - $11.89
Dividend Yield 0%
Revenue per Employee $171,775
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24209M174M35M-21M-16M-0.060
Q4 '23201M164M38M-16M-23M-0.050
Q3 '23196M158M38M-39M-9.8M-0.120
Q2 '23170M124M46M-15M-26M-0.040
Q1 '23241M158M82M-27M36M-0.080

Insider Transactions View All

No recorded Insider transactions.

What is the Market Cap of Evotec?

The Market Cap of Evotec is $1.75B.

How Many People Work at Evotec?

As of our latest update, Evotec employed approximately 4,521 people worldwide. However, it's important to note that Evotec's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Evotec's revenue per employee?

$171,775. To calculate Evotec's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Evotec?

Currently, the price of one share of Evotec stock is $4.87.

How can I analyze the EVO stock price chart for investment decisions?

The EVO stock price chart above provides a comprehensive visual representation of Evotec's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Evotec shares. Our platform offers an up-to-date EVO stock price chart, along with technical data analysis and alternative data insights.

Does EVO offer dividends to its shareholders?

As of our latest update, Evotec (EVO) does not offer dividends to its shareholders. Investors interested in Evotec should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Evotec?

Some of the similar stocks of Evotec are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.